vs
FATE THERAPEUTICS INC（FATE）与WRAP TECHNOLOGIES, INC.（WRAP）财务数据对比。点击上方公司名可切换其他公司
WRAP TECHNOLOGIES, INC.的季度营收约是FATE THERAPEUTICS INC的1.0倍（$1.4M vs $1.4M），WRAP TECHNOLOGIES, INC.同比增速更快（62.3% vs -26.4%），WRAP TECHNOLOGIES, INC.自由现金流更多（$-2.7M vs $-112.0M），过去两年WRAP TECHNOLOGIES, INC.的营收复合增速更高（-2.5% vs -15.7%）
因西斯治疗是1990年成立、总部位于亚利桑那州钱德勒的美国特色制药企业，核心产品Subsys是芬太尼的舌下含服液体制剂。芬太尼是一种见效极快的强效阿片类药物，用于缓解癌症患者爆发性疼痛，在美国，用于该适应症的芬太尼处方通常要求已有记录证明保守疗法无效。
Wrap Technologies是一家公共安全领域的科技企业，主要面向执法、惩戒机构及私营安保部门研发销售非致命性约束设备及配套培训服务，产品覆盖北美及全球多个市场，旨在降低武力使用带来的伤害风险。
FATE vs WRAP — 直观对比
营收规模更大
WRAP
是对方的1.0倍
$1.4M
营收增速更快
WRAP
高出88.7%
-26.4%
自由现金流更多
WRAP
多$109.4M
$-112.0M
两年增速更快
WRAP
近两年复合增速
-15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4M | $1.4M |
| 净利润 | — | $-3.9M |
| 毛利率 | — | 52.3% |
| 营业利润率 | — | -281.1% |
| 净利率 | — | -280.9% |
| 营收同比 | -26.4% | 62.3% |
| 净利润同比 | 37.9% | 48.1% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FATEWRAP
| Q4 25 | $1.4M | $1.4M | ||
| Q3 25 | $1.7M | $1.5M | ||
| Q2 25 | $1.9M | $1.0M | ||
| Q1 25 | $1.6M | $765.0K | ||
| Q4 24 | $1.9M | $865.0K | ||
| Q3 24 | $3.1M | $593.0K | ||
| Q2 24 | $6.8M | $1.6M | ||
| Q1 24 | $1.9M | $1.5M |
净利润FATEWRAP
| Q4 25 | — | $-3.9M | ||
| Q3 25 | $-32.3M | $-2.8M | ||
| Q2 25 | $-34.1M | $-3.7M | ||
| Q1 25 | $-37.6M | $109.0K | ||
| Q4 24 | — | $-7.6M | ||
| Q3 24 | $-47.7M | $2.0M | ||
| Q2 24 | $-38.4M | $-385.0K | ||
| Q1 24 | $-48.0M | $117.0K |
毛利率FATEWRAP
| Q4 25 | — | 52.3% | ||
| Q3 25 | — | 59.2% | ||
| Q2 25 | — | 48.1% | ||
| Q1 25 | — | 77.8% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | — | 39.6% | ||
| Q2 24 | — | 62.6% | ||
| Q1 24 | — | 56.6% |
营业利润率FATEWRAP
| Q4 25 | — | -281.1% | ||
| Q3 25 | -1995.1% | -185.2% | ||
| Q2 25 | -1938.5% | -282.2% | ||
| Q1 25 | -2534.1% | -512.7% | ||
| Q4 24 | — | -535.5% | ||
| Q3 24 | -1703.9% | -611.5% | ||
| Q2 24 | -665.7% | -201.5% | ||
| Q1 24 | -2652.9% | -280.4% |
净利率FATEWRAP
| Q4 25 | — | -280.9% | ||
| Q3 25 | -1852.4% | -186.0% | ||
| Q2 25 | -1786.6% | -368.3% | ||
| Q1 25 | -2309.5% | 14.2% | ||
| Q4 24 | — | -878.3% | ||
| Q3 24 | -1551.0% | 335.6% | ||
| Q2 24 | -567.4% | -24.5% | ||
| Q1 24 | -2493.7% | 7.9% |
每股收益（稀释后）FATEWRAP
| Q4 25 | — | — | ||
| Q3 25 | $-0.27 | $-0.06 | ||
| Q2 25 | $-0.29 | $-0.07 | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.40 | $0.04 | ||
| Q2 24 | $-0.33 | $-0.02 | ||
| Q1 24 | $-0.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.7M | $3.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $207.2M | $11.5M |
| 总资产 | $318.9M | $15.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FATEWRAP
| Q4 25 | $203.7M | $3.5M | ||
| Q3 25 | $215.4M | $6.0M | ||
| Q2 25 | $222.8M | $4.2M | ||
| Q1 25 | $240.4M | $6.2M | ||
| Q4 24 | $279.1M | $3.6M | ||
| Q3 24 | $296.9M | $4.9M | ||
| Q2 24 | $304.9M | $4.6M | ||
| Q1 24 | $121.3M | $8.2M |
股东权益FATEWRAP
| Q4 25 | $207.2M | $11.5M | ||
| Q3 25 | $234.1M | $14.1M | ||
| Q2 25 | $261.4M | $11.8M | ||
| Q1 25 | $288.4M | $2.6M | ||
| Q4 24 | $318.7M | $250.0K | ||
| Q3 24 | $362.3M | $6.4M | ||
| Q2 24 | $397.0M | $3.8M | ||
| Q1 24 | $426.1M | $4.5M |
总资产FATEWRAP
| Q4 25 | $318.9M | $15.4M | ||
| Q3 25 | $343.7M | $18.2M | ||
| Q2 25 | $371.6M | $15.6M | ||
| Q1 25 | $398.7M | $18.0M | ||
| Q4 24 | $440.7M | $15.1M | ||
| Q3 24 | $495.0M | $18.8M | ||
| Q2 24 | $528.8M | $21.8M | ||
| Q1 24 | $569.9M | $24.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.1M | $-2.7M |
| 自由现金流经营现金流 - 资本支出 | $-112.0M | $-2.7M |
| 自由现金流率自由现金流/营收 | -8183.9% | -190.3% |
| 资本支出强度资本支出/营收 | 434.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-199.6M | $-10.4M |
8季度趋势，按日历期对齐
经营现金流FATEWRAP
| Q4 25 | $-106.1M | $-2.7M | ||
| Q3 25 | $-24.4M | $-2.6M | ||
| Q2 25 | $-24.6M | $-1.9M | ||
| Q1 25 | $-33.8M | $-3.1M | ||
| Q4 24 | $-122.9M | $-1.2M | ||
| Q3 24 | $-29.4M | $330.0K | ||
| Q2 24 | $-32.3M | $-3.5M | ||
| Q1 24 | $-33.4M | $-3.7M |
自由现金流FATEWRAP
| Q4 25 | $-112.0M | $-2.7M | ||
| Q3 25 | $-26.6M | $-2.7M | ||
| Q2 25 | $-25.9M | $-1.9M | ||
| Q1 25 | $-35.0M | $-3.1M | ||
| Q4 24 | $-123.6M | $-1.2M | ||
| Q3 24 | $-29.9M | — | ||
| Q2 24 | $-32.4M | $-3.5M | ||
| Q1 24 | $-33.4M | $-3.7M |
自由现金流率FATEWRAP
| Q4 25 | -8183.9% | -190.3% | ||
| Q3 25 | -1526.5% | -181.1% | ||
| Q2 25 | -1360.7% | -192.3% | ||
| Q1 25 | -2148.9% | -401.4% | ||
| Q4 24 | -6645.4% | -139.5% | ||
| Q3 24 | -973.1% | — | ||
| Q2 24 | -477.8% | -224.2% | ||
| Q1 24 | -1736.9% | -253.3% |
资本支出强度FATEWRAP
| Q4 25 | 434.8% | 0.5% | ||
| Q3 25 | 126.5% | 5.7% | ||
| Q2 25 | 71.4% | 0.6% | ||
| Q1 25 | 73.4% | 0.3% | ||
| Q4 24 | 39.2% | 0.1% | ||
| Q3 24 | 16.1% | 0.0% | ||
| Q2 24 | 0.8% | 0.1% | ||
| Q1 24 | 4.5% | 0.9% |
现金转化率FATEWRAP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -28.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
